Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
27.62
+1.04 (3.91%)
At close: Aug 14, 2025, 4:00 PM
27.03
-0.59 (-2.14%)
Pre-market: Aug 15, 2025, 8:00 AM EDT
Apellis Pharmaceuticals (APLS) Product Revenue by Segment
History
| Date | Syfovre | Empaveli |
|---|---|---|
| Jun 30, 2025 | 600.59M | 88.47M |
| Mar 31, 2025 | 604.58M | 92.22M |
| Dec 31, 2024 | 611.85M | 98.13M |
| Sep 30, 2024 | 558.35M | 99.13M |
| Jun 30, 2024 | 481.67M | 98.42M |
| Mar 31, 2024 | 394.39M | 96.21M |
| Dec 31, 2023 | 275.28M | 91.04M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.